Previous 10 | Next 10 |
2024-06-29 07:00:00 ET Pharmaceutical giant Eli Lilly (NYSE: LLY) is having a great year. Shares are up over 50% through the first half of the year on the heels of emerging blockbusters in the diabetes and obesity-care markets. While sales of Mounjaro and Zepbound are becomi...
2024-06-29 06:15:00 ET Eli Lilly (NYSE: LLY) is one of the hottest pharmaceutical companies in the world. The company is quickly gaining steam in the weight loss market thanks to its blockbuster drug , Mounjaro, and its sibling treatment, Zepbound. In addition, earlier this ...
2024-06-28 10:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:55:34 ET This week's dividend activity included increased payouts from Kroger ( NYSE: KR ) and Levi Strauss ( LEVI ) as well as declarations from companies like AT&T ( NYSE: T ) and Pfizer ( NYSE: PFE ).... Read the full article on Seeking...
2024-06-28 04:35:00 ET The market has been ripe with stock splits in recent times, with companies from tech giant Nvidia to fast-casual restaurant chain Chipotle Mexican Grill announcing them. This occurred after these stocks soared in recent years, in many cases reaching into the t...
2024-06-27 16:48:49 ET Summary The small biotech sector has badly underperformed the major market indices so far in 2024. However, that could change as the Federal Reserve cuts interest rates and/or M&A deal volume picks up across the industry. Today, we highlight three sm...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...
2024-06-27 14:14:36 ET Summary Top-line data from Part B of phase 3 RINGSIDE study, using AL102 for the treatment of patients with desmoid tumors, expected 2nd half of 2025. The global desmoid tumor market is projected to grow to $5.49 billion by 2032. IM-1021 is an antibody-d...
2024-06-27 09:36:33 ET More on Hims & Hers Health Hims & Hers: Buy The Dip To Catch The Next Rip Hims & Hers: The Undervalued Gem Poised For Growth Hims & Hers: Compounded Semaglutide Boost Unlikely To Last - Moderate Risks Ahead Hims & He...
2024-06-26 09:26:08 ET Read the full article on Seeking Alpha For further details see: Augustine Therapeutics raises EUR 17M in Series A first closing
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...